Rheumatoid arthritis (RA) care in 2025 has witnessed significant advancements that reflect both innovative...
rheumatoid arthritis
An international collaboration led by researchers at UMC Utrecht has successfully developed two first-in-class...
Johnson & Johnson’s newly-approved drug, Imaavy, has encountered a significant setback after failing to...